| Revolutionizing healthcare: the role of artificial intelligence in clinical practice SA Alowais, SS Alghamdi, N Alsuhebany, T Alqahtani, AI Alshaya, ... BMC medical education 23 (1), 689, 2023 | 187 | 2023 |
| The emergent role of artificial intelligence, natural learning processing, and large language models in higher education and research T Alqahtani, HA Badreldin, M Alrashed, AI Alshaya, SS Alghamdi, ... Research in Social and Administrative Pharmacy, 2023 | 78 | 2023 |
| Comparison of the incidence of acute kidney injury during treatment with vancomycin in combination with piperacillin–tazobactam or with meropenem MS Al Yami Journal of infection and public health 10 (6), 770-773, 2017 | 46 | 2017 |
| Parents' hesitancy to vaccinate their 5–11-year-old children against COVID-19 in Saudi Arabia: predictors from the health belief model OS Almalki, OM Alfayez, MS Al Yami, YA Asiri, OA Almohammed Frontiers in public health 10, 842862, 2022 | 43 | 2022 |
| Antidepressants and health-related quality of life (HRQoL) for patients with depression: analysis of the medical expenditure panel survey from the United States OA Almohammed, AA Alsalem, AA Almangour, LH Alotaibi, MS Al Yami, ... PLoS One 17 (4), e0265928, 2022 | 42 | 2022 |
| Incidence of diabetic ketoacidosis among pediatrics with type 1 diabetes prior to and during COVID-19 pandemic: a meta-analysis of observational studies OM Alfayez, KS Aldmasi, NH Alruwais, NM Bin Awad, MS Al Yami, ... Frontiers in endocrinology 13, 856958, 2022 | 37 | 2022 |
| Network meta-analysis of nine large cardiovascular outcome trials of new antidiabetic drugs OM Alfayez, MS Al Yami, M Alshibani, SB Fallatah, NM Al Khushaym, ... Primary care diabetes 13 (3), 204-211, 2019 | 28 | 2019 |
| Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis MS Al Yami, MA Silva, JL Donovan, AO Kanaan Journal of thrombosis and thrombolysis 45, 36-47, 2018 | 25 | 2018 |
| Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis OM Alfayez, OA Almohammed, OS Alkhezi, AR Almutairi, MS Al Yami Cardiovascular Diabetology 19, 1-14, 2020 | 23 | 2020 |
| Update on cardiovascular safety of incretin-based therapy in adults with type 2 diabetes mellitus: a meta-analysis of cardiovascular outcome trials OM Alfayez, AR Almutairi, A Aldosari, MS Al Yami Canadian journal of diabetes 43 (7), 538-545. e2, 2019 | 18 | 2019 |
| Survival outcomes in iron chelated and non-chelated patients with lower-risk myelodysplastic syndromes: Review and pooled analysis of observational studies I Abraham, M Al Yami, S Yun, HJ Kim, ND Vincelette, A McBride, ... Leukemia research 57, 104-108, 2017 | 16 | 2017 |
| Direct oral anticoagulants for the treatment of venous thromboembolism in patients with active malignancy: a systematic review and meta-analysis MS Al Yami, HA Badreldin, AH Mohammed, AM Elmubark, MY Alzahrani, ... Journal of thrombosis and thrombolysis 46, 145-153, 2018 | 15 | 2018 |
| The impact of pharmacists providing direct patient care as members of interprofessional teams on diabetes management OM Alfayez, MS Al Yami, MT Fazel Saudi Pharmaceutical Journal 25 (7), 1019-1021, 2017 | 14 | 2017 |
| Prevalence, patterns and predictors of depression treatment among community-dwelling older adults with stroke in the United States: a cross sectional study S Bhattacharjee, M Al Yami, S Kurdi, DR Axon BMC psychiatry 18, 1-14, 2018 | 12 | 2018 |
| Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: meta-analysis and risk/benefit assessment MS Al Yami, S Kurdi, I Abraham Journal of Blood Medicine, 25-34, 2018 | 12 | 2018 |
| Risk factors associated with trastuzumab-induced cardiotoxicity in patients with human epidermal growth factor receptor 2-positive breast cancer W Abdel-Razaq, M Alzahrani, M Al Yami, F Almugibl, M Almotham, ... Journal of Pharmacy and Bioallied Sciences 11 (4), 348-354, 2019 | 11 | 2019 |
| Update in cardiovascular safety of glucagon like peptide-1 receptor agonists in patients with type 2 diabetes. A mixed treatment comparison meta-analysis of randomised … MS Al Yami, OM Alfayez, R Alsheikh Heart, Lung and Circulation 27 (11), 1301-1309, 2018 | 11 | 2018 |
| Comparative risk of acute kidney injury following concurrent administration of vancomycin with piperacillin/tazobactam or meropenem: A systematic review and meta-analysis of … AM Alshehri, MY Alzahrani, MA Abujamal, MH Abdalla, SA Alowais, ... Antibiotics 11 (4), 526, 2022 | 9 | 2022 |
| The prescribing pattern of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in patient with type two diabetes mellitus: A two-center … GB Korayem, OA Alshaya, AA Alghamdi, SS Alanazi, MS Al Yami, ... Frontiers in Public Health 10, 1031306, 2022 | 8 | 2022 |
| The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines NS Alsubaie, SM Al Rammah, RA Alshouimi, MY Alzahrani, MS Al Yami, ... Thrombosis Journal 19, 1-11, 2021 | 8 | 2021 |
